Top Markets
Coin of the day
Relmada Therapeutics, Inc. Relmada Therapeutics, Inc.

Relmada Therapeutics, Inc.

RLMD
Rang în acțiuni #13829
Relmada Therapeutics, Inc. operates as a clinical-stage biotechnology company... Relmada Therapeutics, Inc. operates as a clinical-stage biotechnology company in the United States. The company focuses on the development of NDV-01, a controlled-release intravesical formulation of gemcitabine and docetaxel, which is in Phase 2 clinical trial for patients with aggressive forms of non-muscle invasive bladder cancer; and Sepranolone, a neurosteroid epimer of allopregnanolone, which is Phase 2b-ready for the potential treatment of prader-willi syndrome, tourette syndrome, excessive tremor, and other diseases related to excessive GABAergic activity. The company has an agreement with Asarina Pharma AB and Trigone. Relmada Therapeutics, Inc. was founded in 2004 and is headquartered in Coral Gables, Florida.
Preț acțiune
$4.36
Capitalizare de piață
$457.32M
Schimbare (1 zi)
0.69%
Schimbare (1 an)
289.29%
Țară
US
Tranzacționează Relmada Therapeutics, Inc. (RLMD)

Categorie

Istoricul randamentului dividendelor pentru Relmada Therapeutics, Inc. (RLMD)
Randamentul dividendelor (TTM) pentru Relmada Therapeutics, Inc. (simbol acțiune: RLMD) la data de 2026 este: 0
Randamentul mediu al dividendelor în ultimii 5 ani: 0.00%
Istoric al randamentului dividendelor pentru Relmada Therapeutics, Inc. (RLMD) între 2026 și 2026
Randamentul dividendelor la sfârșitul fiecărui an (TTM)
An Randamentul dividendelor Schimbă
Nu sunt suficiente date pentru perioada selectată.
Randamentele dividendelor (TTM) pentru companii similare sau concurente
Companie Randamentul dividendelor Țara
0.00%
US
0.00%
NL
3.12%
AU
0.00%
US
0.00%
CH